PBM Accountability Project Statement on Senate Commerce Committee Progress on PBM Transparency Act
News
The Era of Rebate Rip-offs Is Over (Maybe)
Drug-Prices Investigation Focused on Middlemen Opens in Congress
Video: Senators Criticize PBMs at Recent Hearing
Senate Committee Puts PBMs Under the Microscope
'In the crosshairs': PBM reform effort intensifies on Capitol Hill
PBMs Get Heavy Dose of Criticism at Senate Hearing
Senate begins quest to demystify PBMs' practices as it mulls legislation
Chairman of the Board Response to U.S. Senators’ Efforts to Hold PBMs Accountable
Senators question why PBMs 'even exist' in heated hearing amid push for reform
Tough day for PBMs
How 3 companies came to dominate the PBM market
Mark Cuban Assails PBMs at AAM meeting
Health care giant Centene settles with another state, California
PBM Accountability Project Chairman of the Board Response to State of the Union address
Biden’s SOTU Targets Drug Companies, But Misses Opportunity To Challenge Health Insurers And PBMs
States, not Federal Government, Are Moving to Tighten Regulation of PBMs
Need a new drug? You may be asked to ‘fail’ an old drug first
Bipartisan Policy Center Brief: High Drug Prices: Are PBMs the Right Target?
Centene to pay $66.5 million in Indiana Medicaid drug pricing settlement
Corporate bad actors make billions from abusing program designed to help low-income patients | Guest
Why Now Is the Time for Health Plans to Take Control of Pharmacy Benefits
It is Time for Policymakers to Protect Patients from Predatory Practices of Insurers and PBMs
Lawmakers are readying fresh attacks on pharmacy middlemen